P3 Health Partners (NASDAQ:PIII) Trading 8.9% Higher – Still a Buy?

P3 Health Partners Inc. (NASDAQ:PIII) was up 8.9% during mid-day trading on Monday . The company traded as high as $10.91 and last traded at $10.48. Approximately 34,665 shares changed hands during mid-day trading, an increase of 36% from the average session volume of 25,404 shares. The stock had previously closed at $9.62.

Analysts Set New Price Targets

PIII has been the subject of several research analyst reports. Weiss Ratings upgraded P3 Health Partners from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, May 28th. Wall Street Zen raised P3 Health Partners to a “hold” rating in a research note on Saturday, July 4th. Lake Street Capital restated a “buy” rating and set a $14.00 target price (up from $4.00) on shares of P3 Health Partners in a report on Friday, May 15th. TD Cowen reaffirmed a “hold” rating and issued a $14.00 target price (up from $3.00) on shares of P3 Health Partners in a research report on Friday, May 22nd. Finally, UBS Group set a $14.00 target price on P3 Health Partners in a research report on Friday, May 15th. One analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $14.00.

P3 Health Partners Stock Performance

The company’s 50-day simple moving average is $11.46 and its 200 day simple moving average is $5.92. The company has a market cap of $76.02 million, a PE ratio of -0.27 and a beta of 1.62.

P3 Health Partners (NASDAQ:PIII) last posted its quarterly earnings data on Thursday, May 14th. The company reported $0.32 earnings per share for the quarter, topping analysts’ consensus estimates of ($4.85) by $5.17. The company had revenue of $386.39 million for the quarter, compared to analysts’ expectations of $391.45 million.

Institutional Investors Weigh In On P3 Health Partners

An institutional investor recently bought a new stake in P3 Health Partners stock. Lido Advisors LLC acquired a new stake in P3 Health Partners Inc. (NASDAQ:PIII) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm acquired 10,748 shares of the company’s stock, valued at approximately $33,000. Lido Advisors LLC owned 0.15% of P3 Health Partners as of its most recent filing with the Securities and Exchange Commission. 7.75% of the stock is owned by hedge funds and other institutional investors.

P3 Health Partners Company Profile

P3 Health Partners is a healthcare technology and services company that delivers data-driven solutions to support health plans in improving quality measures, risk adjustment accuracy and operational efficiency. The company’s platform integrates advanced analytics, reporting capabilities and workflow automation to help clients optimize performance across value-based care programs and regulatory requirements.

The company’s core offerings include quality measurement and reporting for HEDIS, STAR and other performance frameworks, risk adjustment coding and audit services, and population health analytics.